HomeCompareHLVX vs NNN

HLVX vs NNN: Dividend Comparison 2026

HLVX yields 95.69% · NNN yields 5.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HLVX wins by $3.24M in total portfolio value
10 years
HLVX
HLVX
● Live price
95.69%
Share price
$2.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.26M
Annual income
$1,067,397.24
Full HLVX calculator →
NNN
NNN REIT Inc.
● Live price
5.66%
Share price
$42.03
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.5K
Annual income
$2,622.67
Full NNN calculator →

Portfolio growth — HLVX vs NNN

📍 HLVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHLVXNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HLVX + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HLVX pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLVX
Annual income on $10K today (after 15% tax)
$8,133.97/yr
After 10yr DRIP, annual income (after tax)
$907,287.65/yr
NNN
Annual income on $10K today (after 15% tax)
$481.32/yr
After 10yr DRIP, annual income (after tax)
$2,229.27/yr
At 15% tax rate, HLVX beats the other by $905,058.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLVX + NNN for your $10,000?

HLVX: 50%NNN: 50%
100% NNN50/50100% HLVX
Portfolio after 10yr
$1.64M
Annual income
$535,009.96/yr
Blended yield
32.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

HLVX
Analyst Ratings
1
Buy
5
Hold
Consensus: Hold
Price Target
$32.00
+1431.1% upside vs current
Range: $30.00 — $34.00
Altman Z
-2.3
Piotroski
3/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+6.9% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLVX buys
0
NNN buys
2
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$NNN▼ Sell$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$NNN▲ Buy$1,001 - $15,0002025-06-17
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002023-05-25
Ro Khanna🏢 House$NNN▼ Sell$1,001 - $15,0002022-01-20
Zoe Lofgren🏢 House$NNN▲ Buy$1,001 - $15,0002021-09-30
Zoe Lofgren🏢 House$NNN▼ Sell$1,001 - $15,0002020-03-23
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHLVXNNN
Forward yield95.69%5.66%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$3.26M$25.5K
Annual income after 10y$1,067,397.24$2,622.67
Total dividends collected$2.90M$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold
Analyst price target$32.00$44.93

Year-by-year: HLVX vs NNN ($10,000, DRIP)

YearHLVX PortfolioHLVX Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$20,269$9,569.38$10,735$614.96+$9.5KHLVX
2$39,816$18,127.60$11,572$708.43+$28.2KHLVX
3$75,882$33,279.13$12,531$819.53+$63.4KHLVX
4$140,469$59,275.00$13,633$952.29+$126.8KHLVX
5$252,850$102,548.32$14,909$1,111.84+$237.9KHLVX
6$443,065$172,515.34$16,392$1,304.77+$426.7KHLVX
7$756,599$282,519.41$18,129$1,539.52+$738.5KHLVX
8$1,260,443$450,881.99$20,173$1,827.08+$1.24MHLVX
9$2,050,673$701,999.14$22,597$2,181.81+$2.03MHLVX
10$3,261,617$1,067,397.24$25,491$2,622.67+$3.24MHLVX

HLVX vs NNN: Complete Analysis 2026

HLVXStock

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

Full HLVX Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this HLVX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLVX vs SCHDHLVX vs JEPIHLVX vs OHLVX vs KOHLVX vs MAINHLVX vs ADCHLVX vs EPRTHLVX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.